These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37188605)

  • 21. Corrigendum to "1,2-diacetylbenzene impaired hippocampal memory by activating proinflammatory cytokines and upregulating the prolactin pathway: An in vivo and in vitro study" [Int. Immunopharmacol. 108 (2022) 108901].
    Nguyen HD; Jo WH; Hoang NHM; Yu BP; Chung HY; Kim MS
    Int Immunopharmacol; 2022 Oct; 111():109156. PubMed ID: 35995727
    [No Abstract]   [Full Text] [Related]  

  • 22. Corrigendum to "Anti-arthritis effect of berberine associated with regulating energy metabolism of macrophages through AMPK/HIF-1α pathway". [Int. Immunopharmacol. 87 (2020) 106830].
    Yu Y; Cai W; Zhou J; Lu H; Wang Y; Song Y; He R; Pei F; Wang X; Zhang R; Liu H; Wei F
    Int Immunopharmacol; 2021 Oct; 99():107911. PubMed ID: 34353734
    [No Abstract]   [Full Text] [Related]  

  • 23. Corrigendum to "Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway" [Int. Immunopharmacol. 36 (2016) 132-141].
    Yao H; Hu C; Yin L; Tao X; Xu L; Qi Y; Han X; Xu Y; Zhao Y; Wang C; Peng J
    Int Immunopharmacol; 2019 Sep; 74():105786. PubMed ID: 31402320
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum to "Sinomenine inhibits fibroblast-like synoviocyte proliferation by regulating α7nAChR expression via ERK/Egr-1 pathway" [Int. Immunopharmacol. 56 (2018) 65-70].
    Yi L; Lyu YJ; Peng C; Zhu RL; Bai SS; Liu L; Wang PX; Zhou H; Dong Y
    Int Immunopharmacol; 2018 Sep; 62():339. PubMed ID: 30007832
    [No Abstract]   [Full Text] [Related]  

  • 25. Corrigendum to "Sodium houttuyfonate enhances the intestinal barrier and attenuates inflammation induced by Salmonella typhimurium through the NF-κB pathway in mice" [Int. Immunopharmacol. 89 (2020) 107058].
    Zhang L; Lv H; Li Y; Dong N; Bi C; Shan A; Wu Z; Shi B
    Int Immunopharmacol; 2021 Mar; 92():107351. PubMed ID: 33444920
    [No Abstract]   [Full Text] [Related]  

  • 26. Corrigendum to "Intravenous immunoglobulin alleviates Japanese encephalitis virus-induced peripheral neuropathy by inhibiting the ASM/ceramide pathway" [Int. Immunopharmacol. 133 (2024) 112083].
    Zhang N; Wang G; Yang L; Zhang J; Yuan Y; Ma L; Wang H; Wang Z
    Int Immunopharmacol; 2024 Jun; 134():112270. PubMed ID: 38762402
    [No Abstract]   [Full Text] [Related]  

  • 27. Corrigendum to "The environmental hormone nonylphenol interferes with the therapeutic effects of G protein-coupled estrogen receptor specific agonist G-1 on murine allergic rhinitis" [Int. Immunopharmacol. 78 (2019) 106058].
    Wang YX; Gu ZW; Hao LY
    Int Immunopharmacol; 2020 Mar; 80():106184. PubMed ID: 31983589
    [No Abstract]   [Full Text] [Related]  

  • 28. Corrigendum to "Ghrelin attenuates secondary brain injury following intracerebral hemorrhage by inhibiting NLRP3 inflammasome activation and promoting Nrf2/ARE signaling pathway in mice" [Int. Immunopharmacol. 79 (2020) 106180].
    Cheng Y; Chen B; Xie W; Chen Z; Yang G; Cai Y; Shang H; Zhao W
    Int Immunopharmacol; 2020 Jul; 84():106461. PubMed ID: 32278662
    [No Abstract]   [Full Text] [Related]  

  • 29. Corrigendum to "Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis" [Int. Immunopharmacol. 77 (2019) 105968].
    Jiang Y; Hu F; Li Q; Shen C; Yang J; Li M
    Int Immunopharmacol; 2020 Jul; 84():106318. PubMed ID: 32115350
    [No Abstract]   [Full Text] [Related]  

  • 30. Blocking ADAM17 Function with a Monoclonal Antibody Improves Sepsis Survival in a Murine Model of Polymicrobial Sepsis.
    Mishra HK; Ma J; Mendez D; Hullsiek R; Pore N; Walcheck B
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corrigendum to "Isosteroid alkaloids with different chemical structures from Fritillariae cirrhosae bulbus alleviate LPS-induced inflammatory response in RAW 264.7 cells by MAPK signaling pathway" [Int. Immunopharmacol. 78 (2020) 106047].
    Liu S; Yang T; Ming TW; Gaun TKW; Zhou T; Wang S; Ye B
    Int Immunopharmacol; 2020 Jul; 84():106482. PubMed ID: 32278661
    [No Abstract]   [Full Text] [Related]  

  • 32. Corrigendum to "Epigallocatechin gallate potentially abrogates fluoride induced lung oxidative stress, inflammation via Nrf2/Keap1 signaling pathway in rats: An in-vivo and in-silico study" [Int. Immunopharmacol. 39 (2016) 128-139].
    Shanmugam T; Selvaraj M; Poomalai S
    Int Immunopharmacol; 2020 Mar; 80():106203. PubMed ID: 31983588
    [No Abstract]   [Full Text] [Related]  

  • 33. Corrigendum to "Alpha-Mangostin suppresses interleukin-1β-induced apoptosis in rat chondrocytes by inhibiting the NF-κB signaling pathway and delays the progression of osteoarthritis in a rat model" [Int. Immunopharmacol. 52 (2017) 156-162].
    Pan T; Chen R; Wu D; Cai N; Shi X; Li B; Pan J
    Int Immunopharmacol; 2018 Dec; 65():559-560. PubMed ID: 30412853
    [No Abstract]   [Full Text] [Related]  

  • 34. Corrigendum to "Integrated population pharmacokinetics of immunoglobulin G following intravenous or subcutaneous administration of various immunoglobulin products in patients with primary immunodeficiencies" [Int. Immunopharmacol. 113(Part A) (2022) 109331].
    Li Z; Follman K; Freshwater E; Engler F; Yel L
    Int Immunopharmacol; 2023 Jan; 114():109555. PubMed ID: 36527876
    [No Abstract]   [Full Text] [Related]  

  • 35. Corrigendum to "Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function" [Int. Immunopharmacol. (2015) 423-432].
    Sun J; Shen X; Dong J; Zhao J; Zuo L; Wang H; Li Y; Zhu W; Gong J; Li J
    Int Immunopharmacol; 2016 Jun; 35():341. PubMed ID: 27130814
    [No Abstract]   [Full Text] [Related]  

  • 36. [Relationship of myeloid differentiation-2 gene promoter polymorphisms with susceptivity of complications after severe trauma in Chinese Han population].
    Gu W; Shan YA; Liu Q; Zhou J; Jiang DP; Yao YZ; Zhang LY; Du DY; Gao JM; Dong H; Yang C; Zhu PF; Wang ZG; Jiang JX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Aug; 29(4):484-7. PubMed ID: 19209789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corrigendum to "Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice" [Int. Immunopharmacol. 102 (2022) 108411].
    Hao J; Sun W; Xu H
    Int Immunopharmacol; 2022 Mar; 104():108550. PubMed ID: 35067473
    [No Abstract]   [Full Text] [Related]  

  • 38. Corrigendum to "IDO1: An important immunotherapy target in cancer treatment" [Int. Immunopharmacol. 47 (2017) 70-77].
    Li F; Zhang R; Li S; Liu J
    Int Immunopharmacol; 2017 Aug; 49():231. PubMed ID: 28457914
    [No Abstract]   [Full Text] [Related]  

  • 39. Corrigendum to "Icariin targets Nrf2 signaling to inhibit microglia-mediated neuroinflammation" [Int. Immunopharmacol. 73 (2019) 304-311].
    Zheng Y; Zhu G; He J; Wang G; Li D; Zhang F
    Int Immunopharmacol; 2020 Nov; 88():107004. PubMed ID: 32950402
    [No Abstract]   [Full Text] [Related]  

  • 40. Corrigendum to "Effect of chlorogenic acid on mast cell-dependent anaphylactic reaction" [Int. Immunopharmacol. 10 (2010) 1135-1141].
    Qin HD; Shi YQ; Liu ZH; Li ZG; Wang HS; Wang H; Liu ZP
    Int Immunopharmacol; 2019 Nov; 76():105863. PubMed ID: 31473097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.